share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Apr 17 16:21
Summary by Moomoo AI
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 23,124 Class A shares on 04/17/2024, as per the latest filing. The shares to be sold were acquired through various means including Pre IPO Option Exercise, Restricted Stock Vesting, and ESPP Purchase, with acquisition dates ranging from 04/20/2021 to 02/15/2023. The transactions were made either as compensation or through cash payments. This planned sale follows a series of transactions over the past three months, where a total of 127,500 shares were sold for gross proceeds of approximately $1.49 million.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 23,124 Class A shares on 04/17/2024, as per the latest filing. The shares to be sold were acquired through various means including Pre IPO Option Exercise, Restricted Stock Vesting, and ESPP Purchase, with acquisition dates ranging from 04/20/2021 to 02/15/2023. The transactions were made either as compensation or through cash payments. This planned sale follows a series of transactions over the past three months, where a total of 127,500 shares were sold for gross proceeds of approximately $1.49 million.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more